Search 

Who we are?

Founded in 2002, Frontier Science (Scotland) Ltd (FSS) is an independent, not-for-profit specialised contract research organisation committed to raising the bar when it comes to designing, running and analysing the results of clinical trials.

We’re a team of 40+ individuals, united in our goal of working on projects that result in public benefit. Our mission is to use a collaborative approach to provide effective, agile solutions and expertise, helping to advance the knowledge of clinical trials, research and statistical science. We have over 20 years of expertise in data management, biostatistics and quality in worldwide clinical trials.

We’re based in the Highlands of Scotland and enjoy an affiliation with Frontier Science organisations in the United States and Greece, as well as worldwide collaborations with customers in industry, academia and health services.

Our Values

 We work with integrity

 We collaborate

 We’re customer-centred

 Continuous learning is at our core

Why work with us?

● Our functional service provision (FSP) approach means that our team will work seamlesslyalongside yours, giving you support in whichever form you need it most

● We’ve been supporting our customers’ clinical trials for over two decades, adapting to

technological advancements along the way

● Our team is highly experienced and committed, providing our clients with support in the design, conduct and analysis of clinical trials

● Our unique position as a not-for-profit partner means we are able to maintain independence and focus on the integrity of the data and analyses we deliver

Biostatistics expertise at your fingertips

Our experienced team of programmers, data analysts and statisticians provide consultancy, regulatory submission and academic research services for studies of all shapes and sizes. Tap into our biostatistics expertise to be sure of accurate, interpretable results.

Biostatistics Services

 Protocol Design Consultancy

 Statistics Analysis Plan (SAP)

 Analyses for Research Projects

 Sample Size Calculations

 Creation of CDSIC datasets

 Reporting

 Independent Data Monitoring Committee (IDMC)

 Regulatory Submissions

 Publishing Results

Data Management - high-quality data delivered on time

Our team of data managers, project managers and database programmers have decades of combined experience. This means you can rely on us to deliver clean, accurate, complete and reliable clinical trial datasets for analysis, every time.

Data Management Services

 Database Design

 Pre-Analysis Database Lock Procedures

 Data Management Documentation

 Data Validation and Integrity

 CDISC Data Extraction

 Case Report Form (CRF) design and annotation

 Data Cleaning

 Reporting

Quality you can count on

We treat quality assurance, quality management systems and technical writing as specialist services alongside our data management and biostatistics expertise. Working with us ensures that every stakeholder in your study can have the utmost confidence in the results.

Quality Services

 Regulatory & Standards Compliance

 Technical Writing

 Clinical Monitoring

 Clinical Quality Management System (QMS) Development

 Trial Master File (TMF) Services

 Pharmacovigilance

Senior Management Team

Our leadership team blends decades of substantial subject matter expertise with business, strategic and people skills. The team is headed up by Dr Darren Gibson, MBA, who joined Frontier Science Scotland in January 2022 with over 20 years of international experience in the health, medical research and innovation sectors.

Fusion Antibodies plc is a early discovery partner located in Belfast, which designs, and optimizes therapeutic antibodies for the global healthcare market. Working with early-stage Biotechs, Fusion’s expertise, process frameworks, and development platforms, enables our clients to develop therapeutics within the most challenging modalities and diseases. Fusion guides them through early-stage antibody discovery, in the most efficient and effective way ensuring that the clients can achieve their goals.


The Company was established in 2001 as a spin out from Queen's University Belfast, with an ordinary share offering on AIM on 18th December 2017. Fusion Antibodies provides a broad range of services in antibody generation, development, production, characterisation, and optimisation. These services include antigen expression, antibody production, purification, sequencing, and antibody humanisation. Fusion's proprietary CDRx® and RAMP® platforms provide the clients with antibodies that have a superior probability of reaching the patients.


Since 2012, Fusion Antibodies has successfully developed over 275 antibodies for an international client base. The Company’s growth strategy is based on combining the latest technological advances with cutting edge science to deliver new platforms, such as OptiMAL®, an unique Mammalian display service offering, that will enable Biotech companies to get to the clinic faster, with the optimal drug candidate.